By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Covalon Technologies Ltd.

Covalon Technologies Ltd. (CVALF)

OTC Market Data in USD, Fundamentals in CAD
$1.70
-$0.04
-2.30%
Last Update: 3 Sept 2025, 17:29
$46.61M
Market Cap
15.38
P/E Ratio (TTM)
Forward Dividend Yield
$1.46 - $3.08
52 Week Range

CVALF Stock Price Chart

Explore Covalon Technologies Ltd. interactive price chart. Choose custom timeframes to analyze CVALF price movements and trends.

CVALF Company Profile

Discover essential business fundamentals and corporate details for Covalon Technologies Ltd. (CVALF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

18 Apr 2007

Employees

CEO

Brent Ashton

Description

Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; and medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. Its products include wound care dressings; surgical and peri-operative products; and infection management products. The company offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. The company is headquartered in Mississauga, Canada.

CVALF Financial Timeline

Browse a chronological timeline of Covalon Technologies Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 26 May 2026

Upcoming earnings on 19 Feb 2026

Upcoming earnings on 19 Feb 2026

Earnings released on 21 Aug 2025

EPS came in at $0.00 surpassing the estimated -$0.04 by +104.25%, while revenue for the quarter reached $6.15M , missing expectations by -41.40%.

Earnings released on 28 May 2025

EPS came in at $0.01 falling short of the estimated $0.04 by -75.00%, while revenue for the quarter reached $5.33M , missing expectations by -42.97%.

Earnings released on 21 Feb 2025

EPS came in at $0.03 surpassing the estimated $0.01 by +200.00%, while revenue for the quarter reached $5.67M , missing expectations by -26.01%.

Earnings released on 7 Jan 2025

EPS came in at $0.01 falling short of the estimated $0.04 by -72.94%, while revenue for the quarter reached $6.53M , missing expectations by -9.97%.

Earnings released on 21 Aug 2024

EPS came in at $0.04 , while revenue for the quarter reached $6.75M .

Earnings released on 29 May 2024

EPS came in at $0.04 , while revenue for the quarter reached $6.20M .

Earnings released on 28 Feb 2024

EPS came in at -$0.02 , while revenue for the quarter reached $3.51M .

Earnings released on 26 Jan 2024

EPS came in at -$0.09 , while revenue for the quarter reached $5.09M .

Earnings released on 16 Aug 2023

EPS came in at -$0.02 , while revenue for the quarter reached $4.73M .

Earnings released on 25 May 2023

EPS came in at -$0.02 , while revenue for the quarter reached $5.35M .

Earnings released on 25 Jan 2023

EPS came in at -$0.12 , while revenue for the quarter reached $4.61M .

Earnings released on 19 Dec 2022

EPS came in at -$0.12 , while revenue for the quarter reached $3.94M .

Earnings released on 29 Aug 2022

EPS came in at -$0.05 , while revenue for the quarter reached $3.51M .

Earnings released on 30 May 2022

EPS came in at -$0.07 , while revenue for the quarter reached $2.63M .

Earnings released on 1 Mar 2022

EPS came in at -$0.04 , while revenue for the quarter reached $3.87M .

Earnings released on 13 Dec 2021

EPS came in at $0.03 , while revenue for the quarter reached -$1.56M .

Earnings released on 30 Aug 2021

EPS came in at $0.03 , while revenue for the quarter reached $7.11M .

Earnings released on 31 May 2021

EPS came in at $0.01 , while revenue for the quarter reached $5.36M .

Earnings released on 1 Mar 2021

EPS came in at -$0.01 , while revenue for the quarter reached $4.69M .

Earnings released on 28 Jan 2021

EPS came in at -$0.06 , while revenue for the quarter reached $4.45M .

CVALF Stock Performance

Access detailed CVALF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run